Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostatin and Docetaxel in Advanced NSCLC
NCT01192230Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jun 2009
- Primary completion
- Dec 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Fudan University. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01192230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192230.